awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33833200-508E3924-A6B5-41F9-AB2F-A7065411FC0E
Q33833200-508E3924-A6B5-41F9-AB2F-A7065411FC0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33833200-508E3924-A6B5-41F9-AB2F-A7065411FC0E
Challenges in using ¹⁸F-fluorodeoxyglucose-PET-CT to define a biological radiotherapy boost volume in locally advanced pancreatic cancer
P2860
Q33833200-508E3924-A6B5-41F9-AB2F-A7065411FC0E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33833200-508E3924-A6B5-41F9-AB2F-A7065411FC0E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
86934beec31e0fc15c16b86de3f4feb47c1b5ce9
P2860
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression.